CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-08 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −19,900 | 19,900 | ||
| 2021-03-08 | Weiner David B. Director | Sale | −3,500 | $9.18 | $32K | 835,385 |
| 2021-03-08 | Weiner David B. Director | Option exercise | +11,667 | 847,052 | ||
| 2021-03-08 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −11,667 | 11,666 | ||
| 2021-03-08 | KIES PETER CFO | Option exercise | +21,467 | 153,749 | ||
| 2021-03-08 | KIES PETER CFO | Shares withheld for taxes | −11,288 | $8.91 | $101K | 142,461 |
| 2021-03-08 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −21,467 | 21,466 | ||
| 2021-03-05 | Kim Jong Joseph Chief Executive Officer | Option exercise | +120,100 | 1,198,413 | ||
| 2021-03-05 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −64,230 | $9.19 | $590K | 1,134,183 |
| 2021-03-05 | Kim Jong Joseph Chief Executive Officer | Option exercise · Restricted Stock Unit | −120,100 | 0 | ||
| 2021-03-05 | Humeau Laurent Chief Scientific Officer | Option exercise | +27,566 | 52,066 | ||
| 2021-03-05 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −9,632 | $9.19 | $89K | 42,434 |
| 2021-03-05 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −27,566 | 0 | ||
| 2021-03-05 | Weiner David B. Director | Option exercise | +11,666 | 838,885 | ||
| 2021-03-05 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −11,666 | 0 | ||
| 2021-03-05 | KIES PETER CFO | Option exercise | +27,566 | 146,856 | ||
| 2021-03-05 | KIES PETER CFO | Shares withheld for taxes | −14,574 | $9.19 | $134K | 132,282 |
| 2021-03-05 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −27,566 | 0 | ||
| 2021-02-26 | Weiner David B. Director | Grant or award · Common Stock Option | +60,000 | 60,000 | ||
| 2021-02-26 | Weiner David B. Director | Grant or award · Restricted Stock Unit | +35,000 | 35,000 |
Page 26 of 32 · 622 trades